Home Markets Lilly sees strong growth in 2026 as weight-loss drug rival Novo slips

Lilly sees strong growth in 2026 as weight-loss drug rival Novo slips

Feb 04, 2026 comments off

Original source: https://www.investing.com/news/stock-market-news/eli-lilly-sees-2026-profit-above-estimates-on-weightloss-drug-demand-4484339

You May Also Like

Analysis-Apple’s foldable iPhone poses a $1,999 question: Who is it for?

Nikkei 225 tests 62,880 support in bearish standoff: Live levels

SK Hynix coils mid-range after bearish engulfing: Live levels

Analysis-Apple’s foldable iPhone poses a $1,999 question: Who is it for?

U.S. stock futures steady with CPI on tap; Oracle firms on strong earnings

Oracle’s quarterly revenue beats estimates as AI boom drives cloud demand